Non-ST-Elevation Myocardial Infarction in a Case of Von Willebrand Disease: a Case Report

  • Anees Abdul Department of Emergency Medicine, Baby Memorial Hospital, Kerala, India
  • Arpith Easo Samuel Department of Emergency Medicine, Baby Memorial Hospital, Kerala, India
  • Fabith Moideen Department of Emergency Medicine, Baby Memorial Hospital, Kerala, India
  • Jayasree Nambiar Department of Cardiology, Baby Memorial Hospital, Kerala, India
Keywords: Case reports, Disease management, Myocardial infarction, von Willebrand Diseases


Introduction: Studies have shown that patients with Von Willebrand disease (VWD) have decreased prevalence of thrombotic events like myocardial infarction (MI). Here we describe a case of VWD with acute non-ST-elevation MI with ongoing bleeding manifestations. Case presentation: A 37-year-old female patient presented to the emergency department with a complaint of central chest pain since 7 days. She also had a history of hemoptysis since 8 days. Electrocardiogram (ECG) revealed ST-segment depression in leads I, aVL, II, III, aVF, and V4-V6 compatible with diagnosis of Non-ST-Elevation Myocardial Infarction (Non STEMI). She was started on nitroglycerine infusion, angiotensin II receptor blockers, and calcium channel blockers along with trimetazidine. Her chest pain and ECG changes settled after 2 days, and she was discharged in a stable condition. Conclusion: There are limited studies available regarding the management of acute MI in VWD patients with acute bleeding manifestations. Further studies have to be carried out to determine successful ways of managing thrombotic events like MI in this subset of patients.


Download data is not yet available.


1. Sanders Y, Eikenboom J, de Wee E, van der Bom J, Cnossen M, Degenaar-Dujardin M, et al. Reduced prevalence of arterial thrombosis in von Willebrand disease. J Thromb Haemost. 2013;11(5):845-54.
2. Arjomand H, Aquilina P, McCormick D. Acute myocardial infarction in a patient with von Willebrand disease: pathogenetic dilemmas and therapeutic challenges. J Invasive Cardiol. 2002;14(10):615-8.
3. James PR, de Belder AJ, Kenny MW. Successful percutaneous transluminal coronary angioplasty for acute myocardial infarction in von Willebrand's disease. Haemophilia. 2002;8(6):826-7.
4. Fragasso G, Camba L, Pizzetti G, Pagnotta P, Chierchia SL. Successful thrombolysis for acute myocardial infarction in Type I von Willebrand's disease (vWD). Am J Hematol. 1998;57(2):180.
5. Spiel A, Gilbert J, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117(11):1449-59.
6. Rutten B, Maseri A, Cianflone D, Laricchia A, Cristell N, Durante A, et al. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study. Eur Heart J Acute Cardiovasc Care. 2015;4(1):64-74.
7. Sonneveld M, Cheng J, Oemrawsingh R, de Maat M, Kardys I, Garcia-Garcia H, et al. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thromb Haemost. 2015;113(3):577-84.
8. Hassan S, Amer S, Qureshi W, Alirhayim Z, Kuriakose P. Treating symptomatic coronary artery disease in patients with Von Willebrand disease. Hematol Oncol Stem Cell Ther. 2013;6(3-4):101-4.
How to Cite
Abdul, A., Samuel, A., Moideen, F., & Nambiar, J. (2018). Non-ST-Elevation Myocardial Infarction in a Case of Von Willebrand Disease: a Case Report. Advanced Journal of Emergency Medicine, 2(4), e47.
Case (report / study)